Jan. 26 (Bloomberg) -- Jeffrey Kraws, chief executive officer and co-founder of Crystal Research Associates, talks with Bloomberg's Carol Massar about Pfizer Inc.'s agreement to buy Wyeth for about $68 billion in the largest pharmaceutical acquisition in almost five years. Kraws also discusses the outlook for additional consolidation in the pharmaceutical industry.
Link to this comment:
All Comments (0)